Serum metabolomics reveals the intervention mechanism and compatible regularity of Chaihu Shu Gan San on chronic unpredictable mild stress-induced depression rat model.


Journal

The Journal of pharmacy and pharmacology
ISSN: 2042-7158
Titre abrégé: J Pharm Pharmacol
Pays: England
ID NLM: 0376363

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 01 12 2019
accepted: 04 04 2020
pubmed: 19 5 2020
medline: 14 4 2021
entrez: 19 5 2020
Statut: ppublish

Résumé

To provide a comprehensive study of the intervention mechanism and compatible regularity of Chaihu Shu Gan San (CSGS) in a chronic unpredictable mild stress (CUMS)-induced depression model. Ethological study and ELISA assay were applied to measure the phenotypes of depression after CUMS stimulate and assess the antidepressant activity of fluoxetine, CSGS and its compatibilities. The serum metabolic profile changes were revealed by untargeted Q/TOF MS-based metabolomics followed by multivariate statistical analysis. CSGS exhibits an significant intervention effect on CUMS-induced depression. After the multivariate statistical analysis, 17 potential serum biomarkers were identified and 16 of them could be regulated by CSGS. The intervention of CSGS on CUMS-induced depression involved five key pathways. Moreover, each functional unit (monarch, minister, assistant and guide medicine) in CSGS regulates different metabolites and metabolic pathways to achieve different effects on antidepressant; however, their intervention efficacies are inferior to the holistic formula, which may be due to the synergism of bioactive ingredients in the seven herbs of CSGS. CSGS produced an obvious antidepressant activity. The comprehensive and holistic metabolomics approach could be a powerful tool to study the intervention mechanism and the compatibility rule of traditional Chinese medicine.

Identifiants

pubmed: 32419180
doi: 10.1111/jphp.13286
doi:

Substances chimiques

Antidepressive Agents 0
Biomarkers 0
Plant Extracts 0
chaihu-shugan-san 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1133-1143

Subventions

Organisme : Youth Science Foundation of Guangxi Medical University
ID : GXMUYSF13
Organisme : Youth Science Foundation of Guangxi Medical University
ID : GXMUYSF18
Organisme : Guangxi First-class Discipline Project for Pharmaceutical Sciences
ID : GXFCDP-PS-2018
Organisme : National Natural Science Foundation of China
ID : 81360638
Organisme : National Natural Science Foundation of China
ID : 81560626
Organisme : National Natural Science Foundation of China
ID : 81603533
Organisme : the National Training Programs of Innovation and Entrepreneurship for Undergraduates of China
ID : 201410598010
Organisme : Pharmaceutical Postgraduate Joint Cultivation Base for Inovation & Entrepreneurship
ID : 20170703
Organisme : Natural Science Foundation of Guangxi Province
ID : 2012GXNSFBA053108
Organisme : Natural Science Foundation of Guangxi Province
ID : 2013GXNSFAA019161
Organisme : program for Scientific Research in Guangxi Higher Education Institutions
ID : 200103YB026

Informations de copyright

© 2020 Royal Pharmaceutical Society.

Références

Faulconbridge LF et al. Changes in symptoms of depression with weight loss: results of a randomized trial. Obesity (Silver Spring) 2009; 17: 1009-1016.
Lavergne F, Jay TM. A new strategy for antidepressant prescription. Front Neurosci-Switz 2010; 4: 1-10.
Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiat 2003; 54: 227-240.
WHO. DEPRESSION: A Global Crisis. World Federation for Mental Health. http://www.who.int/mental_health/management/depression/wfmh_paper_depression_wmhd_2012.pdf
Zis AP, Goodwin FK. Novel antidepressants and the biogenic amine hypothesis of depression. The case for iprindole and mianserin. Arch Gen Psychiatry 1979; 36: 1097-1107.
Watson S et al. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry 2004; 184: 496-502.
Wang Y et al. Meta-analysis of the clinical effectiveness of traditional Chinese medicine formula Chaihu-Shugan-San in depression. J Ethnopharmacol 2012; 141: 571-577.
Simon GE et al. Suicide risk during antidepressant treatment. Am J Psychiatry 2006; 163: 41-47.
Rajkowska G, Miguel-Hidalgo JJ. Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 2007; 6: 219-233.
Jing LL et al. Effect of Xiaoyaosan on major depressive disorder. Chin Med 2015; 10: 18.
Jia Hongmei et al. Metabonomics combined with UPLC-MS chemical profile for discovery of antidepressant ingredients of a traditional chinese medicines formula, Chaihu-Shu-Gan-San. Evid Based Complement Alternat Med 2013; 2013: 487158.
Zhang HW, Zou ZM. Application in clinic and research advances of ChaiHu-Shu-Gan-San. Lishizhen Med Mater Med Res 2007; 18: 1234-1236.
Zhao L et al. Simultaneous determination of oleanolic and ursolic acids in rat plasma by HPLC-MS: application to a pharmacokinetic study after oral administration of different combinations of QingGanSanJie decoction extracts. J Chromatogr Sci 2015; 53: 1185-1192.
Zh S et al. Hippocampus and serum metabolomic studies to explore the regulation of Chaihu-Shu-Gan-San on metabolic network disturbances of rats exposed to chronic variable stress. Mol BioSyst 2014; 10: 549-561.
Nicholson JK, Lindon JC. Systems biology: metabonomics. Nature 2008; 455: 1054-1056.
Chang X et al. Role of Bai-Shao towards the antidepressant effect of Chaihu-Shu-Gan-San using metabonomics integrated with chemical fingerprinting. J Chromatogr B Analyt Technol Biomed Life Sci 2015; 1006: 16-29.
Gika HG et al. Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. J Proteome Res 2007; 6: 3291-3303.
Zhang H et al. Metabolomic study of corticosterone-induced cytotoxicity in PC12 cells by ultra performance liquid chromatography-quadrupole/time-of-flight mass spectrometry. Mol BioSyst 2016; 12: 902-913.
Su ZH et al. Online identification of the antioxidant constituents of traditional Chinese medicine formula Chaihu-Shu-Gan-San by LC-LTQ-Orbitrap mass spectrometry and microplate spectrophotometer. J Pharmaceut Biomed 2010; 53: 454-461.
Jiang ML et al. Antidepressant-like effect of evodiamine on chronic unpredictable mild stress rats. Neurosci Lett 2015; 588: 154-158.
Anisman H et al . Stress, depression, and anhedonia: Caveats concerning animal models. Neuroscience & Biobehavioral Reviews 2005; 29: 525-546.
Qiao H et al. Dendritic spines in depression: what we learned from animal models. Neural Plast 2016; 2016: 8056370.
Muller CP et al. Brain membrane lipids in major depression and anxiety disorders. Biochim Biophys Acta 2015; 1851: 1052-1065.
Taniguchi M. Oakzaki T. The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration-from cell and animal models to human disorders☆. Biochem Biophys Acta 2014; 1841: 692-703.
Alkhudairy L et al. Omega 6 fatty acids for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2015; 11: CD011094.
Tsuchimine S et al. Decreased serum levels of polyunsaturated fatty acids and folate, but not brain-derived neurotrophic factor, in childhood and adolescent females with depression. Psychiatry Res 2015; 225: 187-190.
Blanchard H et al. Brain arachidonic acid incorporation and turnover are not altered in the flinders sensitive line rat model of human depression. Neurochem Res 2015; 40: 2293-2303.
Yao Y et al. Deciphering the combination principles of Traditional Chinese Medicine from a systems pharmacology perspective based on Ma-huang Decoction. J Ethnopharmacol 2013; 150: 619-638.
Jia W et al. The rediscovery of ancient Chinese herbal formulas. Phytother Res 2004; 18: 681-686.

Auteurs

Hongye Zhang (H)

Pharmaceutical College, Guangxi Medical University, Nanning, China.
Department of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, China.

Huimin Huang (H)

Pharmaceutical College, Guangxi Medical University, Nanning, China.

Hui Song (H)

Pharmaceutical College, Guangxi Medical University, Nanning, China.

Bonnie Chin (B)

Pharmaceutical College, Guangxi Medical University, Nanning, China.

Hua Zheng (H)

Medical Scientific Research Center, Guangxi Medical University, Nanning, China.

Junxiang Ruan (J)

Pharmaceutical College, Guangxi Medical University, Nanning, China.

Fang Wu (F)

Pharmaceutical College, Guangxi Medical University, Nanning, China.

Bang Cheng (B)

Pharmaceutical College, Guangxi Medical University, Nanning, China.

Jinxia Wu (J)

Pharmaceutical College, Guangxi Medical University, Nanning, China.

Xuwen Liu (X)

Pharmaceutical College, Guangxi Medical University, Nanning, China.

Yonghong Liang (Y)

Pharmaceutical College, Guangxi Medical University, Nanning, China.

Fangming Song (F)

Pharmaceutical College, Guangxi Medical University, Nanning, China.

Zhaoni Chen (Z)

Pharmaceutical College, Guangxi Medical University, Nanning, China.

Chaoling Tang (C)

Pharmaceutical College, Guangxi Medical University, Nanning, China.

Shiyin Lu (S)

Pharmaceutical College, Guangxi Medical University, Nanning, China.

Hongwei Guo (H)

Pharmaceutical College, Guangxi Medical University, Nanning, China.
Key Laboratory of Longevity and Aging-related Diseases of Chinese Ministry of Education & Center for Translational Medicine, Guangxi Medical University, Nanning, China.

Zhongmei Zou (Z)

Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Zhiheng Su (Z)

Pharmaceutical College, Guangxi Medical University, Nanning, China.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH